Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation

Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation

US Patent 11654157 · Granted May 23, 2023

Estimated economic value: $778,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for cancer therapies that include delivery of halogenat2025
Methods and compositions for cancer therapies that include delivery of halogenat2025
Methods and compositions for cancer therapies that include delivery of halogenat2025
Methods and compositions for cancer therapies that include delivery of halogenat2025
Methods and compositions for cancer therapies that include delivery of halogenat2025
Radiation mitigator and method of use thereof2025
Selective histone deacetylase inhibitors for the treatment of human disease2024
Selective histone deacetylase inhibitors for the treatment of human disease2024
Selective histone deacetylase inhibitors for the treatment of human disease2024
Radiation mitigator and method of use thereof2023
Selective histone deacetylase inhibitors for the treatment of human disease2023
Selective histone deacetylase inhibitors for the treatment of human disease2023